LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series.

Photo by nci from unsplash

e21588Background: Immune checkpoint inhibitors are standard of care for most patients (pts) with MM, yet only a minority has durable disease control. CTX has limited activity when used first-line, ... Click to show full abstract

e21588Background: Immune checkpoint inhibitors are standard of care for most patients (pts) with MM, yet only a minority has durable disease control. CTX has limited activity when used first-line, ...

Keywords: melanoma multicenter; utility chemotherapy; immunotherapy failure; metastatic melanoma; chemotherapy immunotherapy; failure metastatic

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.